Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 2995-3004

  Horie, Katsunori ^a   Miyata, Toshio ^b   Maeda, Kenji ^a   Miyata, Satoshi ^c   Sugiyama, Satoshi ^d   Sakai, Hideto ^b   Van Ypersele De Strihou, Charles ^e   Monnier, Vincent M ^f   Witztum, Joseph L ^g   Kurokawa, Kiyoshi ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d CHUKYO HOSPITAL   (Japan)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Advanced glycation end products; Carboxymethyllysine; Local oxidative stress; Malondialdehyde; Pentosidine

Indexed keywords

MALONALDEHYDE;

ARTICLE; DIABETIC NEPHROPATHY; GLOMERULOPATHY; GLUCOSE OXIDATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0031453830     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119853     Document Type: Article

References (55)

1. 1995. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int. 47: 1703-1720.
2. Bangstad, H.J., R. Østerby, K. Dahl-Jørgensen, K.J. Berg, A. Hartmann, and K.F. Hanssen. 1994. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia. 37:483-490.
3. Brownlee, M., A. Cerami, and H. Vlassara. 1988. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321.
4. Dyer, D.G., J.A. Dunn, S.R. Thorpe, K.E. Bailie, T.J. Lyons, D.R. McCance, and J.W. Baynes. 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91:2463-2469.
5. Ahmed, M.U., S.R. Thorpe, and J.W. Baynes. 1986. Identification of N∈-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem. 261:4889-4894.
6. Sell, D.R., and V.M. Monnier. 1989. Structure elucidation of a senescence cross-link from human extracellular matrix. J. Biol. Chem. 264:21597-21602.
7. Njoroge, F.G., L.M. Sayre, and V.M. Monnier. 1987. Detection of glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr. Res. 167:211-220.
8. Baynes, J.W., and V.M. Monnier. 1989. The Maillard reaction in aging, diabetes and nutrition. Prog. Clin. Biol. Res. 304:1-410.
9. Baynes, J.W. 1991. Perspectives in diabetes: role of oxidative stress in development of complications in diabetes. Diabetes. 40:405-412.
10. Wells-Knecht, K.J., D.V. Zyzak, J.E. Litchfield, S.R. Thorpe, and J.W. Baynes. 1995. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry. 34:3702-3709.
11. Wells-Knecht, M.A., S.R. Thorpe, and J.W. Baynes. 1995. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 34:15134-15141.
12. Glomb, M.A., and V.M. Monnier. 1995. Mechanism of protein modification by glyoxal and glycoaldehyde, reactive intermediates of the Maillard reaction. J. Biol. Chem. 270:10017-10026.
13. Monnier, V.M., V. Vishwanath, K.E. Frank, C.A. Elmets, P. Dauchot, and P.R. Kohn. 1986. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N. Engl. J. Med. 314:403-408.
14. Sell, D.R., A. Lapolla, P. Odetti, J. Fogarty, and V.M. Monnier. 1992. Pentosidine formation in skin correlates with severity of complication in individuals with long-standing IDDM. Diabetes. 41:1286-1292.
15. McCance, D.R., D.G. Dyer, J.A. Dunn, K.E. Bailie, S.R. Thorpe, J.W. Baynes, and T.J. Lyons, 1993. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 91:2470-2478.
16. Beisswenger, P.J., L.L. Moore, T. Brinck-Johnsen, and T.J. Curphey. 1993. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J. Clin. Invest. 92:212-217.
17. Monnier, V.M., D.R. Sell, R.H. Nagaraj, S. Miyata, S. Grandhee, P. Odetti, and S.A. Ibrahim. 1992. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes. 41:36-41.
18. Kirstein, M., J. Brett, S. Radoff, S. Ogawa, D. Stern, and H. Vlassara. 1990. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc. Natl. Acad. Sci. USA. 87:9010-9014.
19. Vlassara, H., M. Brownlee, K.R. Manogue, C.A. Dinarello, and A. Pasagian. 1988. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science. 240:1546-1548.
20. Miyata, T., R. Inagi, Y. Iida, M. Sato, N. Yamada, O. Oda, K. Maeda, and H. Seo. 1994. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloi-dosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1.J. Clin. Invest. 93:521-528.
21. Iida, Y., T. Miyata, R. Inagi, S. Sugiyama, and K. Maeda. 1994. β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem. Biophys. Res. Commun. 201:1235-1241.
22. Miyata, T., Y. Iida, Y. Ueda, T. Shinzato, H. Seo, V.M. Monnier, K. Maeda, and Y. Wada. 1996. Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products. Kidney Int. 49:538-550.
23. Neeper, M., A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, Y.C. Pan, K. Ellison, D. Stern, and A. Shaw. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. biol. Chem. 267: 14998-15004.
24. Miyata, T,. O. Hori, J. Zhang, S.D. Yan, L. Ferran, Y. Iida, and A.M. Schmidt. 1996. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-β2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. J. Clin. Invest. 98: 1088-1094.
25. Skolnik, E.Y., Z. Yang, Z. Makita, S. Radoff, M. Kirstein, and H. Vlassara. 1991. Human and rat mesangial cell receptors for glucose-modified pro-teins: potential role in kidney tissue remodelling and diabetic nephropathy. J. Exp. Med. 174:931-939.
26. Doi, T., H. Vlassara, M. Kirstein, Y. Yamada, G.E. Striker, and L.J. Striker. 1992. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 89:2873-2877.
27. Brett, J., A.M. Schmidt, S.D. Yan, Y.S. Zou, E. Weidman, D. Pinsky, R. Nowygrod, M. Neeper, C. Przysiecki, A. Shaw, et al. 1993. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143:1699-1712.
28. Soulis-Liparota, T., M. Cooper, D. Papazoglou, B. Clarke, and G. Jerums. 1991. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes. 40:1328-1334.
29. Houglum, K., M. Filip, J.L. Witztum, and M. Chojkier. 1990. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J. Clin. Invest. 86:1991-1998.
30. Grandhee, S.K., and V.M. Monnier. 1991. Mechanism of formation of the Maillard protein cross-link pentosidine. J. Biol. Chem. 266:11649-11653.
31. Miyata, T., S. Taneda, R. Kawai, Y. Ueda, S. Horiuchi, M. Hara, K. Maeda, and V.M. Monnier. 1996. Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc. Natl. Acad. Sci. USA. 93:2353-2358.
32. Miyata, T., Y. Ueda, T. Shinzato, Y. Iida, S. Tanaka, K. Kurokawa, C. van Ypersele de Strihou, and K. Maeda. 1996. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J. Am. Soc. Nephrol. 7:1198-1206.
33. Horiuchi, S., N. Araki, and Y. Morino. 1991. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J. Biol. Chem. 266:7329-7332.
34. Miyata, S., and V.M. Monnier. 1992. Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. J. Clin. Invest. 89:1102-1112.
35. Rosenfeld, M.E., W. Palinski, S.Y. Herttula, S. Butler, and J.L. Witztum. 1990. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:336-349.
36. Palinski, W., S.Y. Herttula, M.E. Rosenfeld, S.W. Butler, S.A. Socher, S. Parthasathy, L.K. Curtiss, and J.L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10:325-335.
37. Miyata, T., O. Oda, R. Inagi, Y. Iida, N. Araki, N. Yamada, S. Horiuchi, N. Taniguchi, K. Maeda, and T. Kinoshita. 1993. β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J. Clin. Invest. 92:1243-1252.
38. Ikeda, K., T. Higashi, H. Sano, Y. Jinnouchi, M. Yoshida, T. Araki, S. Ueda, and S. Horiuchi. 1996. N∈-(carboxymethyl)lisine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry. 35:8075-8083.
39. Miyata, T., Y. Wada, Z. Cai, Y. Iida, K. Horie, K. Maeda, K. Kurokawa, and C. van Ypersele de Strihou. 1997. Implication of an increased oxidative stress in patients with end-stage renal failure. Kidney Int. 51:1170-1181.
40. Reddy, S., J. Bichler, K.J. Wells-Knecht, S.R. Thorpe, and J.W. Baynes. 1995. N∈-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 34:10872-10878.
41. Falk, R.J., J.I. Scheinman, S.M. Mauer, and A.F. Michael. 1983. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes. 32(Suppl. 2):34-39.
42. Makino, H., K. Shikhata, J. Wieslander, J. Wada, N. Kashihara, K. Yoshioka, and Z. Ota. 1993. Localization of fibril/microfibril and basement membrane collagens in diabetic glomerulosclerosis in type 2 diabetes. Diabet. Med. 11:304-311.
43. Mohan, P.S., W.G. Carter, and R.G. Spiro. 1990. Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes. Diabetes. 39:31-37.
44. Dunn, J.A., M.U. Ahmed, M.H. Murtiashaw, J.M. Richardson, M.D. Walla, S.R. Thorpe, and J.W. Baynes. 1990. Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N∈-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry. 29:10964-10970.
45. Dyer, D.G., J.A. Blackledge, S.R. Thorpe, and J.W. Baynes. 1991. Formation of pentosidine during nonenzymatic browning of protein by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. Biol Chem. 266:11654-11660.
46. Portero-Otin, M., R.H. Nagaraj, and V.M. Monnier. 1995. Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo. Biochim. Biophys. Acta. 1247:74-80.
47. Wolff, S.P., and R.T. Dean. 1987. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem. J. 245:243-250.
48. Hunt, J.V., R.T. Dean, and S.P. Wolff. 1988. Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem. J. 256:205-212.
49. Yan, S.D., A.M. Schmit, G.M. Anderson, J. Zhang, Y.S. Zou, D. Pinsky, and D. Stern. 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptor/binding protein. J. Biol. Chem. 269:9889-9897.
50. Yan, S.D., H. Zhu., J. Fu, S.F. Yan, A. Roher, W.W. Tourtellotte, T. Rajavashisth, X. Chen, G.C. Godman, D. Stern, and A.M. Schmit. 1997. Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:5296-5301.
51. Diamond, J.R. 1992. The role of reactive oxygen species in animal models of glomerular disease. Am. J. Kidney Dis. 3:292-300.
52. Johnson, R.J., D. Lovett, R.I. Lehrer, W.G. Couser, and S.J. Klebanoff. 1994. Role of oxidants and proteases in glomerular injury. Kidney Int. 45:352-359.
53. Miyata, T., Y. Ueda, K. Horie, M. Nangaku, S. Tanaka, C. van Ypersele de Strihou, and K. Kurokawa. 1998. Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int. In press.
54. Gugliucci, A., and M. Bendayan. 1996. Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia. 39:149-160.
55. Anderson, M.M., S.L. Hazen, F.F. Hsu, and J.W. Heinecke. 1997. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanol, and acrolein. A mechanism for the generation of highly reactive α-hydroxy and α,-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99:424-432.